12 小时
AZoLifeSciences on MSNTargeting NMDA Receptor Subunit Shows Promise for Fragile X SyndromeBuilding on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...
Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...
US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...
This study reveals that SHANK3 deficiency in brain endothelial cells disrupts BBB function during the neonatal period through β-Catenin imbalance, leading to ASD-related neuronal and behavioral ...
PANAMA CITY, Fla. (WJHG/WECP) -FSU Panama City’s early childhood autism program, also known as ECAP, is one of the only non-profit programs in our area that serves kids with developmental ...
Autism spectrum disorder (ASD) is a group of neurodevelopmental conditions with behavioral, social, and communication symptoms that may be seen as early as the first year of life. Autism spectrum ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果